UIM6:F:F-UBS ETF SICAV - MSCI USA UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 553.48

Change

-1.24 (-0.22)%

Market Cap

USD 0.70B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-09 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.21 (-0.75%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.35 (-0.67%)

USD 116.19B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 109.51B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.46 (-0.81%)

USD 98.97B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 63.27B
SXRZ:F iShares VII PLC - iShares Nikk..

-2.00 (-0.82%)

USD 52.42B
VUSA:F Vanguard Funds Public Limited ..

+0.05 (+0.05%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.29 (+0.26%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

+0.02 (+0.32%)

USD 38.52B
0ZC:F Zscaler Inc

-0.36 (-0.20%)

USD 37.92B

ETFs Containing UIM6:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.27% 43% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.27% 43% F 46% F
Trailing 12 Months  
Capital Gain 31.21% 88% B+ 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 31.21% 85% B 69% C-
Trailing 5 Years  
Capital Gain 95.31% 95% A 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 95.31% 95% A 69% C-
Average Annual (5 Year Horizon)  
Capital Gain 16.34% 89% A- 77% C+
Dividend Return 16.34% 87% B+ 69% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.67% 37% F 77% C+
Risk Adjusted Return 104.33% 94% A 95% A
Market Capitalization 0.70B 70% C- 53% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.